BRISTOL MYERS SQUIBB
- Country
- ๐ซ๐ทFrance
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 60
- Registration Number
- NCT00135343
- Locations
- ๐บ๐ธ
Local Institution, Hampton, Virginia, United States
A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen
- Conditions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 5000
- Registration Number
- NCT00135447
- Locations
- ๐บ๐ธ
Biogenomx Research Institute, LLC/CHC1-AP, Hollywood, Florida, United States
๐บ๐ธInfectious Disease Group of Atlanta, Atlanta, Georgia, United States
๐บ๐ธFamily Healthcare of Atlanta, PC, Atlanta, Georgia, United States
Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism
- Conditions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 25
- Registration Number
- NCT00135434
- Locations
- ๐บ๐ธ
Clinical Pharmacology Unit, Bristol-Myers Squibb Company, Hamilton, New Jersey, United States
A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide
- Conditions
- Interventions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2016-09-28
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 115
- Registration Number
- NCT00135408
- Locations
- ๐ฌ๐ง
Local Institution, Hull, United Kingdom
A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen
- Conditions
- Interventions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2010-02-05
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 200
- Registration Number
- NCT00135395
- Locations
- ๐ต๐ท
Local Institution, Santruce, Puerto Rico
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 271
- Registration Number
- NCT00135421
- Locations
- ๐บ๐ธ
Emory University, Atlanta, Georgia, United States
๐บ๐ธAlbuquerque Neuroscience, Inc., Albuquerque, New Mexico, United States
๐บ๐ธUniversity Of North Carolina At Chapel Hill, Chapel Hill, North Carolina, United States
Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen
- Conditions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2010-02-17
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 254
- Registration Number
- NCT00135382
- Locations
- ๐ต๐ท
Local Institution, Rio Piedras, Puerto Rico
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
- Conditions
- Interventions
- First Posted Date
- 2005-07-29
- Last Posted Date
- 2012-02-27
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 1286
- Registration Number
- NCT00124982
- Locations
- ๐ฌ๐ง
Local Institution, Leeds, North Yorkshire, United Kingdom
Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2015-04-07
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 56
- Registration Number
- NCT00124449
- Locations
- ๐ฌ๐ง
Local Institution, Leeds, North Yorkshire, United Kingdom
Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
- First Posted Date
- 2005-07-25
- Last Posted Date
- 2016-08-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 724
- Registration Number
- NCT00123474
- Locations
- ๐บ๐ธ
Kaiser Permanente Medical Center, Vallejo, California, United States
๐บ๐ธUniversity Of Maryland, Baltimore, Maryland, United States
๐บ๐ธWestern Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, United States